Effects of R-salbutamol on the inflammatory response and acute lung injury in endotoxemic mice

Salbutamol, which consists of an R-isomer and S-isomer, is an effective and widely used 82 adrenoreceptor agonist that may possess anti-inflammatory properties in addition to its bronchodilator activity. Whether the salbutamol R-isomer has advantages over its racemic mixture and effectiveness in treating endotoxemia and endotoxin-induced lung injury has not been well studied. In this study, we investigated the preventive and therapeutic effects of R-salbutamol (R-sal), S-salbutamol (S-sal), and their racemic mixture (Rac-sal) on a mouse model of lipopolysaccharide (LPS)-induced endotoxemia. Dexamethasone (Dex) was used for comparison. The results showed that R-sal markedly improved the 7-day survival rate of endotoxic mice when administered before and after LPS treatment. Dex was toxic and accelerated the death of endotoxic mice when administered before LPS injection. Histological examination of the lungs revealed that the LPS challenge resulted in acute lung damage, including inflammatory cell infiltration, thickened alveolar septa, and congestion. R-sal pre-treatment effectively inhibited these changes, accompanied by markedly reduced lung myeloperoxidase levels, serum cytokine levels, and lactate release, significant restoration of lymphocyte count, and reduction of monocyte count. This may have occurred through inhibition of M1 macrophage inflammatory responses by enhancement of 8-arrestin2 expression and suppression of NF-& kappa;B activation. Rac-sal exhibited diminished effects compared to that of R -sal, while S-sal showed enhanced release of some inflammatory cytokines. In addition, R-sal pre-treatment showed a better improvement in prognostic pulmonary function on day 4 compared to that by Rac-sal. Collec-tively, our results indicate the potential benefits of R-sal in regulating inflammatory responses to endotoxemia and endotoxin-induced lung injury.

Automated summary

This study investigated the effects of R-salbutamol, S-salbutamol, and their racemic mixture on a mouse model of lipopolysaccharide-induced endotoxemia. The results showed that R-salbutamol significantly improved the 7-day survival rate of endotoxic mice. It also effectively inhibited lung damage and reduced inflammatory responses, suggesting its potential benefits in regulating endotoxemia and endotoxin-induced lung injury.